2019 Scientific Program Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution

Patents, Stock and Other Travel, Royalties, Other Expert Other Name Employment Leadership Ownership Honoraria Consulting or Advisory Role Speakers' Bureau Research Funding Accommodations, Intellectual Testimony Relationship Interests Expenses Property Monica M. Leap Syntalogic, Syntimmune Abbvie (Inst), Agenus (Inst), Astellas Pharma (Inst), AstraZeneca Bertagnolli Therapeutics (Inst), Baxalta (Inst), Health (Inst), Breast Cancer Research Foundation (Inst), Bristol-Myers Squibb (Inst), Celgene (Inst), Complion (Inst), Eisai (Inst), Exelixis (Inst), (Inst), GHI Pharma (Inst), (Inst), GlaxoSmithKline (Inst), Incyte (Inst), Janssen (Inst), (Inst), Leidos (Inst), Lexicon (Inst), Lilly (Inst), Matrex (Inst), Mayo Clinic (Inst), Merck (Inst), MGH (Inst), Millenium Pharamceuticals (Inst), (Inst), Patient Centered Outcomes Research Institute (PCORI) (Inst), (Inst), Pharmacyclics (Inst), Robert Wood Johnson Foundation (Inst), Sagerock Advisors (Inst), Sanofi (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst), Tesaro (Inst), Teva (Inst)

Suzanne George , AstraZeneca, Bayer, Blueprint ARIAD (Inst), Bayer (Inst), Blueprint Medicines (Inst), Deciphera UptoDate Bayer Research to Abbvie (I), (I) Medicines, Deciphera, Lilly (Inst), Novartis (Inst), Pfizer (Inst) Practice

Melissa L. Araxes Pharma (Inst), Astellas Abbvie (Inst), Acerta Pharma (Inst), Adaptimmune (Inst), Abbvie, Astellas Pharma, Johnson Pharma (I), AstraZeneca (Inst), (Inst), Array BioPharma (Inst), AstraZeneca (Inst), BeiGene (Inst), AstraZeneca, Boehringer BeiGene (Inst), Boehringer BerGenBio (Inst), Birdie (Inst), Boehringer Ingelheim (Inst), Bristol- Ingelheim, Bristol-Myers Ingelheim (Inst), Bristol-Myers Myers Squibb (Inst), Checkpoint Therapeutics (Inst), Clovis Oncology Squibb, Clovis Oncology, Squibb (Inst), Calithera Biosciences (Inst), Corvus Pharmaceuticals (Inst), CytomX Therapeutics (Inst), Daiichi Sankyo, EMD (Inst), Celgene (Inst), Daiichi Sankyo (Inst), Dynavax (Inst), EMD Serono (Inst), Foundation Serono, Exelixis, Genentech/Roche (Inst), Guardant Medicine (Inst), G1 Therapeutics (Inst), Genentech/Roche (Inst), Genentech, Incyte, Health (Inst), Incyte (Inst), Loxo Genmab (Inst), Genocea Biosciences (Inst), Gritstone Oncology Merck, Pfizer, Sysmex, (Inst), Merck (Inst), Mersana (Inst), (Inst), Guardant Health (Inst), Hengrui Pharmaceutical (Inst), Incyte Vapotherm Mirati Therapeutics (Inst), Otsuka (Inst), Janssen (Inst), Kadmon (Inst), Lilly (Inst), Loxo (Inst), Lycera (I), Pfizer (Inst), Ribon Therapeutics (Inst), Merck (Inst), Mersana (Inst), Mirati Therapeutics (Inst), Neovia (Inst), Sanofi (Inst) Oncology (Inst), Novartis (Inst), OncoMed (Inst), Pfizer (Inst), Regeneron (Inst), Sanofi (Inst), Stem CentRx (Inst), Syndax (Inst), Tarveda Therapeutics (Inst)

Ann H. Partridge

Biostatistics Karla V. Ballman ARIAD, , Takeda Prostate cancer Janssen signature patent Oncology, Lilly (Inst), Immune enrichment signature for response to trastuzumab in HER2+ breast cancer (Inst)

Suzanne E. AstraZeneca Patent pending for Dahlberg a statistical model assessing tumor growth (Inst)

Susan Halabi Eisai, Ferring Pharmaceuticals Kelley M. Kidwell Mallinckrodt

Rosemarie Mick Editas Medicine Infiniti Medical

Mei-Yin Polley Yu Shyr Aduro Biotech, GlaxoSmithKline, Janssen Research & Development, Novartis, Pfizer, Roche/Genentech

Breast Cancer - Metastatic Roisin M. Clovis Oncology (Inst), Genentech/Roche (Inst), Macrogenics (Inst), Syndax Connolly Merck (Inst), Merrimack (Inst), Novartis (Inst), Puma Biotechnology (Inst) Olwen M. Hahn Via Oncology Cardinal Health (I) Pfizer Cardinal Health (I)

Erika P. Boehringer Ingelheim (Inst), Abbvie (Inst), Acerta Pharma (Inst), ArQule (Inst), AstraZeneca (Inst), Amgen, AstraZeneca, Hamilton Cascadian Therapeutics (Inst), BerGenBio (Inst), Boehringer Ingelheim (Inst), Cascadian Bayer, Bristol-Myers Daiichi Sankyo (Inst), Eisai (Inst), Therapeutics (Inst), Clovis Oncology (Inst), Curis (Inst), CytomX Squibb, Clovis Oncology, Flatiron Health, Genentech/Roche Therapeutics (Inst), Daiichi Sankyo (Inst), eFFECTOR Therapeutics Eisai, EMD Serono, (Inst), Lilly (Inst), Mersana (Inst), (Inst), Eisai (Inst), EMD Serono (Inst), Fujifilm (Inst), Foundation Medicine, Pfizer (Inst), Puma Biotechnology Genentech/Roche (Inst), H3 Biomedicine (Inst), Hutchison Genentech, (Inst) MediPharma (Inst), Immunomedics (Inst), InventisBio (Inst), Kadmon Genentech/Roche, (Inst), Leap Therapeutics (Inst), Lilly (Inst), Lycera (Inst), Macrogenics Genzyme, Guardant (Inst), Mallinckrodt (Inst), MedImmune (Inst), Medivation (Inst), Health, Helsinn Mersana (Inst), Merus (Inst), Millennium (Inst), Novartis (Inst), Therapeutics, HERON, Nucana (Inst), OncoMed (Inst), Oncothyreon (Inst), Pfizer (Inst), Lexicon, Lilly, Medivation, PharmaMar (Inst), Radius Health (Inst), Regeneron (Inst), Rgenix Merck, Novartis, Pfizer, (Inst), Stem CentRx (Inst), Syndax (Inst), Syros Pharmaceuticals Roche, Sysmex, Tesaro (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst), TapImmune Inc. (Inst), Tesaro (Inst), TetraLogic Pharmaceuticals (Inst), Verastem (Inst), Zymeworks (Inst)

Virginia G. Celgene, Eisai, Celgene, Eisai, Eisai Kaklamani Genentech, Genentech Genomic Health, Novartis, Pfizer Sara M. Tolaney AstraZeneca, Eisai, Genentech, Bristol-Myers Squibb, Eisai, Exelixis (Inst), Genentech/Roche (Inst), Lilly, Merck, NanoString Lilly (Inst), Merck (Inst), Novartis (Inst), Pfizer (Inst) Technologies, Nektar, Novartis, Pfizer, Puma Biotechnology Nicholas C. AstraZeneca, Bicycle Therapeutics, AstraZeneca (Inst), Bio-Rad (Inst), Clovis Oncology (Inst), Inivata Turner Novartis, Pfizer, Roche, Tesaro (Inst), Pfizer (Inst), Roche (Inst)

Breast Cancer -Local/Regional/Adjuvant Lior Z. Braunstein Eun-Sil S. Hwang Jacqueline S. Jeruss Erica L. Mayer Context Therapeutics, Eisai, Lilly, (Inst), Pfizer (Inst) Novartis, Pfizer Priyanka Almac Diagnostics, AstraZeneca, Bristol-Myers Squibb (Inst), Celgene (Inst), Cosmo Biosciences (Inst), Almac Diagnostics, Sharma Myriad Genetics, Novartis, Pfizer, Novartis (Inst) AstraZeneca TapImmune Vered Stearns Iridium Therapeutics Abbvie, Biocept, MedImmune, Novartis, Pfizer, Puma Biotechnology Immunomedics

Julia R. White Qfix Intraop Medical (Inst) Qfix Cancer Prevention, Genetics, and Epidemiology Veda N. Giri John R. Goffin Amgen, Boehringer Ingelheim, AstraZeneca Bristol-Myers Squibb Erin W. Hofstatter Noelle K. Abbvie, AstraZeneca, Bayer, LoConte Celgene Mark E. Robson AstraZeneca, AstraZeneca, McKesson, Merck Abbvie (Inst), AstraZeneca (Inst), InVitae (Inst), Medivation (Inst), AstraZeneca Pfizer Myriad Genetics (Inst), Pfizer (Inst), Tesaro (Inst) Central Nervous System Tumors E. Antonio DNAtrix Merck Advantagene, Alcyone Amgen Patents related to Chiocca Lifesciences, DNAtrix, Insigthec, oncolytic virus NanoTX, Oncorus, Sigilon, technology, gene StemGen, Tocagen, ZIOPHARM therapy, Oncology microRNA, exosome, antibodies Timothy F. Notable Labs Abbvie, Agios, Alexion Global Coalition Cloughesy Pharmaceuticals, Boehringer for Adaptive Ingelheim, Boston Biomedical, Research Bristol-Myers Squibb, Celgene, 501(c)(3) Cortice, Deciphera, Genocea Biosciences, GW Pharmaceuticals, Human Longevity, Inc, Insys Therapeutics, KIYATEC, Lilly, Merck, NewGen Therapeutics, Notable Labs, Novartis, Novocure, Novogen, Oxigene, Pfizer, Puma Biotechnology, Roche/Genentech, Sunovion, Tocagen, VBI Vaccines, VBL Therapeutics,

Evanthia Abbvie (Inst), Genentech/Roche Genentech/Roche (Inst), Merck (Inst) Galanis (Inst), Oncorus Monica Malik Developmental Immunotherapy and Tumor Immunobiology Sanjay Goel Oncolytics (Inst) I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364

James L. Gulley Astellas Medivation (Inst), Bavarian Nordic (Inst), Bristol-Myers Squibb (Inst), EMD Serono (Inst), Merck (Inst), NantBioScience (Inst), Pfizer (Inst) Aparna Kalyan Samumed Bristol-Myers Squibb (Inst) Ross L. Levine Qiagen Loxo Incyte Novartis Celgene, Roche Heather L. Amgen, Calithera Biosciences, Bristol-Myers Squibb (Inst), Lilly (Inst), MedImmune (Inst), Merck Amgen, Calithera Lilly, OBI Pharma McArthur Immunomedics, Lilly, Merck, OBI (Inst), ZIOPHARM Oncology (Inst) Biosciences, Pharma, Peregrine Immunomedics, Lilly, Pharmaceuticals, Pfizer, Roche, Merck, OBI Pharma, , Syndax Puma Biotechnology, Roche, Spectrum Pharmaceuticals Matthew I. BioClin Therapeutics Acerta Pharma (Inst), Astellas Pharma (Inst), AstraZeneca (Inst), Roche/Genentech Milowsky Bristol-Myers Squibb (Inst), Clovis Oncology (Inst), Incyte (Inst), Inovio Pharmaceuticals (Inst), Merck (Inst), Pfizer (Inst), Roche/Genentech (Inst), Seattle Genetics (Inst), X4 Pharmaceuticals (Inst) Kurt A. Schalper Takeda Celgene, Shattuck Labs Therapeutics, Navigate BioPharma, Onkaido Therapeutics, Pierre Fabre, Surface Oncology, Takeda, Tesaro, Vasculox

Padmanee Apricity (I), BioAtla (I), Amgen (I), Apricity (I), BioAtla, Own patent Sharma Codiak Biosciences BioMx, Codiak Biosciences (I), licensed to Jounce, (I), Constellation Constellation Pharmaceuticals, Own patents Pharmaceuticals, Forty Seven (I), ImaginAb (I), licensed to BMS, Forty Seven (I), Jounce Therapeutics (I), Kite Jounce & Merck (I) ImaginAb (I), Jounce Pharma (I), Marker Therapeutics Therapeutics (I), (I), Merck, Neon Therapeutics (I), Marker Therapeutics Oncolytics, Pieris Pharmaceuticals, (I), Neon Polaris (I), TapImmune Inc. (I), Therapeutics (I), Tvardi Therapeutics (I) Oncolytics, Polaris (I), TapImmune Inc. (I), Tvardi Therapeutics (I)

Developmental Therapeutics and Tumor Biology (Nonimmuno) Gregory M. Cote 2nd.MD, Advance Medical, Grand Agios (Inst), Boston Biomedical (Inst), CBA (Inst), Eisai (Inst), Rounds Health, InfiniteMD Epizyme (Inst), Macrogenics (Inst), Merck KGaA (Inst), PharmaMar (Inst), Plexxikon (Inst) William D. Figg Astellas Pharma (Inst), Biocompatibles (Inst), Celgene (Inst), Nerviano Medical Sciences (Inst), NovaRX (Inst), Pfizer (Inst), TRACON Pharma (Inst) R D. Harvey Genentech, HERON, Spectrum Genentech Agensys (Inst), Amgen (Inst), ArQule (Inst), AstraZeneca (Inst), Pharmaceuticals AVEO (Inst), Bristol-Myers Squibb (Inst), Calithera Biosciences (Inst), Celgene (Inst), Cleave Biosciences (Inst), Eisai (Inst), Merck (Inst), Millennium (Inst), Novartis (Inst), Pfizer (Inst), Sanofi (Inst), Takeda (Inst) David M. Hyman AstraZeneca, Atara AstraZeneca, Loxo, Puma Biotechnology Chugai Pharma, Biotherapeutics, Bayer, Boehringer Genentech Ingelheim, Chugai Pharma, CytomX Therapeutics, Debiopharm Group, Genentech, Pfizer

Christophe Le Bristol-Myers Amgen, AstraZeneca, Bristol-Myers AstraZeneca, Bristol- Tourneau Squibb, Novartis Squibb, Merck Serono, MSD Myers Squibb, MSD

Kyriakos P. ArQule (Inst), Bayer (Inst) 3D Medicines (Inst), Abbvie (Inst), ADC Therapeutics (Inst), Amgen Papadopoulos (Inst), ARMO BioSciences (Inst), ArQule (Inst), Calithera Biosciences (Inst), Curegenix (Inst), Daiichi Sankyo (Inst), EMD Serono (Inst), Formation Biologics (Inst), Incyte (Inst), Jounce Therapeutics (Inst), MabSpace Biosciences (Inst), MedImmune (Inst), Merck (Inst), Mersana (Inst), OncoMed (Inst), Peloton Therapeutics (Inst), Regeneron (Inst), Sanofi (Inst), Syros Pharmaceuticals (Inst)

Geoffrey Shapiro Almac Diagnostics, Astex Aileron Therapeutics (Inst), Array BioPharma (Inst), AstraZeneca Patent #: 9872874 Bayer, Bicycle Pharmaceuticals, Bayer, Bicycle (Inst), Bayer (Inst), CanBas (Inst), Cellceutix (Inst), Covidien (Inst), Title: Dosage Therapeutics, G1 Therapeutics, Cybrexa Curis (Inst), (Inst), Genentech (Inst), GlaxoSmithKline (Inst), regimen for Therapeutics, Lilly, Therapeutics, Fusion Immune Design (Inst), Lilly (Inst), Merck (Inst), Merck Serono (Inst), sapacitabine and Pfizer, Sierra Oncology Pharmaceuticals, G1 Therapeutics, Millennium (Inst), Mirati Therapeutics (Inst), Novartis (Inst), Pfizer seliciclib Ipsen, Lilly, Merck Serono, Pfizer, (Inst), PharmaMar (Inst), PTC Therapeutics (Inst), Puma Issue Date: Roche, Sierra Oncology Biotechnology (Inst), Roche (Inst), Sanofi (Inst), Seattle Genetics 1/23/2018 (Inst), Sierra Oncology (Inst), Syros (Inst), Tensha Therapeutics Provisional Patent (Inst), Tesaro (Inst), Vertex (Inst) #: 62/538,319 Title: Compositions and methods for predicting response and resistance to CDK4/6 inhibition Filed: 7/28/17

Eddy S. Yang AstraZeneca, Strata Oncology Clovis Oncology (Inst), Lilly (Inst), Novartis (Inst) Strata Oncology

Gastrointestinal (Colorectal) Cancer Jordan Berlin Nestle Health Abbvie, Arno Therapeutics, Bayer (Inst), BeiGene (Inst), Boston Biomedical (Inst), EMD Serono Abbvie, Bayer, EMD AstraZeneca Science AstraZeneca, Bayer Health, (Inst), Five Prime Therapeutics (Inst), Genentech/Roche (Inst), Gilead Serono, Nestle Health BeiGene, Celgene, Cornerstone Sciences (Inst), Immunomedics (Inst), Incyte (Inst), Karyopharm Science, Seattle Pharmaceuticals, Eisai, EMD Therapeutics (Inst), Loxo (Inst), Macrogenics (Inst), Pharmacyclics Genetics Serono, ERYTECH Pharma, (Inst), Symphogen (Inst), Taiho Pharmaceutical (Inst) Exelixis, Five Prime Therapeutics, Genentech/Roche, Gritstone Oncology, Karyopharm Therapeutics, lsk biopharma, Seattle Genetics

Andrea Cercek Amgen, Bayer Abbvie, Amgen, Bayer Jennifer R. Eads Bristol-Myers Amgen, Exelixis, Novartis AstraZeneca (Inst), Bayer (Inst), Bristol-Myers Squibb (Inst), Calithera AstraZeneca/ Squibb (I) Biosciences (Inst), EMD Serono (Inst), HealthCare Pharmaceuticals MedImmune (I), Bristol- (Inst), Merck (Inst), Symphony Evolution (Inst), Verastem (Inst) Myers Squibb (I)

Cathy Eng Bayer, Celgene, Bayer Schering Pharma, Advaxis, Forty Seven, Genentech/Roche, Keryx Bayer, Roche, Sirtex Roche/Genentech, Taiho Genentech/Roche, Sirtex Medical Pharmaceutical Medical Mark Kozloff Abbvie, Abbvie, Genentech/Roche Abbvie, Amgen, Genentech/ Genentech/Roche, Roche Lilly, Merck, Tesaro Christopher H. Merck, Merrimack Immune Design Lieu Fotios Loupakis Amgen, Bayer, Sanofi Amgen, Bayer, Amgen (Inst), Bayer (Inst), Merck Serono (Inst), Roche (Inst) Amgen, Merck Serono, Roche, Sanofi Roche Wen Wee Ma Athenex (Inst), Merrimack (Inst) Ritesh Rathore AstraZeneca, Bristol- AstraZeneca, Bristol- Myers Squibb Myers Squibb

Hanna K. Sanoff Bayer (Inst), Merck (Inst)

Gastrointestinal (Noncolorectal) Cancer Steven Ades Jennifer A. Chan Merck Ipsen Advanced Accelerator Applications, Lilly (Inst), Sanofi (Inst) Exelixis, Ipsen, Novartis

Sarah E. Hoffe Varian Medical IBA Varian Medical Varian Medical Systems (Inst) Varian Medical Systems Systems Systems Matthew H. Katz Abbvie, Alcresta Therapeutics

Marcus S. Noel Celgene Taiho Pharmaceutical Manisha Palta Duke University Oakstone Navigant Consulting Merck (Inst) UpToDate Publishing Vaibhav Sahai Celgene, Celgene Agios (Inst), Bristol-Myers Squibb (Inst), Celgene (Inst), Clovis Halozyme, Ipsen, Oncology (Inst), Incyte (Inst) Merrimack, Newlink Genetics

Sunil Sharma Beta Cat ARIAD, Array LSK BioPharma, Natera Bayer (Inst), Blueprint Medicines (Inst), Gilead Sciences (Inst), Patent: Substituted BioTherapeutics Delivery Pharmaceuticals, BioPharma, Blend GlaxoSmithKline (Inst), Incyte (Inst), Johnson & Johnson (Inst), N-(3(Pyrimidin-4- Society, Five Prime ConverGene, Therapeutics, MedImmune (Inst), Merck (Inst), Millennium (Inst), Novartis (Inst), YL)Phenyl)Acrylam Therapeutics, HeritX, Proterus Exelixis, Onyx (Inst), Plexxikon (Inst), XuanZhu (Inst) ide Analogs as LSK Biopharma, Therapeutics, Foundation Tyrosine Receptor Translational Genomics Salarius Medicine, Genesis Kinase BTK Research Institute Pharmaceuticals, StiL Biotechnology Inhibitors. U.S. Forschungs, Stingray Group, Guardant Patent No. US Therapeutics Health, Loxo, 9,296,703, B2. Novartis, US Patent: Oncology “Substituted N-(3- (Pyrimidin-4- YL)Phenyl)Acrylam ide Analogs as Tyrosine Receptor Kinase BTK Inhibitors”. U.S. Patent No. 9,206,176.

Bradley G. Somer Keith R. Unger Jiping Wang GenomiCare GenomiCare GenomiCare GenomiCare GenomiCare Genitourinary (Nonprostate) Cancer Karim Chamie AstraZeneca, Urogen Pharma Altor BioScience Toni K. Choueiri Alexion , Alligent, Agensys (Inst), AstraZeneca (Inst), Bayer (Inst), Bristol-Myers Squibb Pharmaceuticals, Analysis Group, ASCO, (Inst), Calithera Biosciences (Inst), Celldex (Inst), Cerulean Pharma Analysis Group, AstraZeneca, Bayer, Bristol-Myers (Inst), Corvus Pharmaceuticals (Inst), Eisai (Inst), Exelixis (Inst), ASCO, Squibb, Cerulean Pharma, Clinical Foundation Medicine (Inst), GlaxoSmithKline (Inst), Ipsen (Inst), AstraZeneca, Care Options, Corvus Merck (Inst), Novartis (Inst), Peloton Therapeutics (Inst), Pfizer (Inst), Bayer, Bristol- Pharmaceuticals, Eisai, Exelixis, Prometheus (Inst), Roche (Inst), Roche/Genentech (Inst), Seattle Myers Squibb, Foundation Medicine, Genetics/Astellas (Inst), Takeda (Inst), TRACON Pharma (Inst) Cerulean Pharma, GlaxoSmithKline, Harborside Clinical Care Press, Ipsen, Kidney Cancer Options, Corvus Journal, Lancet Oncology, Lpath, Pharmaceuticals, Merck, Michael J. Hennessy Eisai, Exelixis, Associates, Navinata Healthcare, Foundation NCCN, NEJM, Novartis, PlatformQ, Medicine, Peloton Therapeutics, Pfizer, Genentech/ Prometheus Laboratories, Roche, Roche/Genentech, Sanofi/Aventis, GlaxoSmithKline, UpToDate Harborside Press, Ipsen, Kidney Cancer Journal, Lancet Oncology, Lpath, Merck, Michael J. Hennessy Associates, Navinata Healthcare, NCCN, NEJM, Novartis, Peloton Therapeutics, PER, Pfizer, PlatformQ Health, Prometheus, Sanofi/Aventis, UpToDate

Petros Grivas AstraZeneca, Biocept, Bristol- Bristol-Myers Squibb AstraZeneca (Inst), Bavarian Nordic (Inst), Bayer (Inst), Clovis Myers Squibb, Clovis Oncology, Oncology (Inst), Genentech/Roche (Inst), Immunomedics (Inst), Driver, Inc, EMD Serono, Merck (Inst), Mirati Therapeutics (Inst), Oncogenex (Inst), Pfizer (Inst) Foundation Medicine, Genentech, HERON, Janssen, Merck, Pfizer, QED Therapeutics, Seattle Genetics

Rana R. McKay Bristol-Myers Squibb/Pfizer, Bayer (Inst), Pfizer (Inst) Exelixis, Janssen, Novartis, Tempus Andrea Necchi AstraZeneca, AstraZeneca, Bayer, BioClin AstraZeneca (Inst), Merck Sharp & Dohme (Inst) AstraZeneca, Janssen, Janssen, Merck, Therapeutics, Clovis Oncology, Merck Sharp & Dohme, Roche Incyte, Janssen, Merck Sharp & Roche Dohme, Roche, Seattle Genetics/Astellas Daniel E. Spratt

Genitourinary (Prostate) Cancer Tanya B. Dorff AstraZeneca, Bayer, Eisai, EMD Exelixis, Pfizer, Bayer, Bristol-Myers Squibb Serono, Janssen Oncology, Roche Prometheus Laboratories Felix Y. Feng PFS Genomics PFS Genomics Dendreon, EMD Serono, Ferring, I helped develop a Janssen Oncology, Sanofi molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst) Anthony M. Aptevo Therapeutics (Inst), Bayer (Inst), Bristol-Myers Squibb (Inst), Joshua Janssen Oncology (Inst), Lilly (Inst), Macrogenics (Inst), Mayne Pharma (Inst), Merck Sharp & Dohme (Inst), Roche/Genentech (Inst)

Timur Mitin Oregon Health & UpToDate Advance Medical Novocure UpToDate chapter Science Via Oncology royalty University (OHSU) Ganesh S. NantKwest Janssen Scientific Affairs Minomic Implantable Palapattu nanotechnology for long term testosterone delivery, functionalized fiducial marker for drug delivery

Mary-Ellen Astellas Pharma, AstraZeneca, Bayer, Best Doctors, Bayer (Inst), Janssen-Ortho (Inst), Medivation (Inst), Pfizer (Inst), Astellas Pharma, Bayer, Taplin Bayer, Clovis Clovis Oncology, Guidepoint Tokai Pharmaceuticals (Inst) Clovis Oncology, Incyte, Oncology, Incyte, Global, Incyte, Janssen-Ortho, Janssen Oncology, Janssen-Ortho, Myovant Sciences, Pfizer, Medivation, Pfizer, Tokai Pfizer, Research to Research to Practice, UpToDate Pharmaceuticals Practice, UpToDate

Gynecologic Cancer Kevin V. Pfizer/EMD Serono (Inst) Albuquerque Linda R. Duska Advance Medical, British Journal of Abbvie (Inst), Aduro Biotech (Inst), Advaxis (Inst), Aeterna Zentaris Genentech, Obstetrics and Gynecology, (Inst), Bristol-Myers Squibb (Inst), Cerulean Pharma (Inst), MedImmune, ClearView Healthcare Partners, GlaxoSmithKline (Inst), Merck (Inst), Millennium (Inst), Novartis (Inst), Merck Merck, Parexel, UpToDate Pfizer (Inst), Syndax (Inst), Tesaro (Inst)

Patricia J. Eifel Adaptive Intracavitary Brachytherapy Applicator - Patent, The University of Texas MD Anderson Cancer Center and Nucletron

Rachel N. Mateon Therapeutics Grisham Helen Mackay Karen McLean Head and Neck Cancer Maura L. Gillison Aspyerian Therapeutics, AstraZeneca (Inst), Bristol-Myers Squibb (Inst), Merck (Inst) AstraZeneca, Bristol-Myers Squibb, Celgene, EMD Serono, Merck

K. William Harter Faye M. PIQUR Johnson Jochen H. Lorch Bayer, Eisai Bayer (Inst), Bristol-Myers Squibb (Inst), Millennium (Inst), Novartis (Inst) Steven F. Powell Bristol-Myers Squibb (Inst) Bristol-Myers Squibb (Inst), Genentech/Roche (Inst), Incyte (Inst), Merck Sharp & Dohme (Inst), Novartis (Inst), Pfizer (Inst), Vyriad (Inst) Ravindra Merck Merck Uppaluri Health Services Research, Clinical Informatics & Quality of Care Gabriel A. Abt Associates, CareCentrix Brooks Stewart B. Fleishman Rachel A. Eisai (Inst), Puma Biotechnology (Inst) Freedman Faithlore P. BioTheranostics, Oasis 360 Gardner Ronald S. Go OnLive, Takeda Jack W. London TriNetX

Jimmy Ruiz AstraZeneca AstraZeneca, Genentech Erica T. Warner

Hematologic Malignancies-Leukemia, MDS, and Allotransplant Juliet N. Barker Angiocrine Angiocrine Bioscience Angiocrine Bioscience, Gamida Cell Magenta Bioscience, Therapeutics Gamida Cell, Nohla Therapeutics

John C. Byrd Acerta Pharma, Genentech, Jazz Acerta Pharma (Inst), Genentech (Inst), Janssen (Inst), Pharmaceuticals, Pharmacyclics Pharmacyclics (Inst)

Caitlin Costello Adaptive Biotechnologies, Celgene, Celgene (Inst), Janssen (Inst), Takeda (Inst) Takeda Takeda Leslie R. Ellis Alexion Alexion Pharmaceuticals Alexion Alexion Pharmaceuticals, Pharmaceuticals Pharmaceuticals ASH Mehdi Hamadani Celgene ADC Therapeutics, Cellerant Celgene, Genzyme Astellas Pharma, Genzyme, Otsuka US, Spectrum Pharmaceuticals, Therapeutics, Incyte Coporation, Takeda Janssen Research & Development, MedImmune, Pharmacyclics, Puma Biotechnology (I)

Hematologic Malignancies-Lymphoma and CLL Nancy L. Bartlett Kite Pharma, Pfizer, Seattle Affimed Therapeutics (Inst), Bristol-Myers Squibb (Inst), Celgene Genetics (Inst), Dynavax (Inst), Forty Seven (Inst), Genentech (Inst), Gilead Sciences (Inst), Immune Design (Inst), Janssen (Inst), Kite Pharma (Inst), MedImmune (Inst), Merck (Inst), Millennium (Inst), Novartis (Inst), Pfizer (Inst), Pharmacyclics (Inst), Seattle Genetics (Inst)

Matthew S. Abbvie, AstraZeneca, Celgene, Abbvie (Inst), Bristol-Myers Squibb (Inst), Genentech (Inst), Infinity TG Therapeutics Davids Genentech, InCyte, Janssen, MEI Pharmaceuticals (Inst), MEI Pharma (Inst), Pharmacyclics (Inst), Pharma, Merck, Pharmacyclics, TG Surface Oncology (Inst), TG Therapeutics (Inst) Therapeutics John P. Leonard Abbvie, ADC Therapeutics, Juno Therapeutics AstraZeneca, Bayer, Biotest, Bristol- Myers Squibb, Celgene, Epizyme, Genentech/Roche, Genmab, Gilead Sciences, Juno Therapeutics, MEI Pharma, NanoString Technologies, Novartis, Pfizer, Regeneron, Sunesis Pharmaceuticals, Sutter Medical Group

Tycel J. Phillips Bayer, Genentech, Bayer, Genentech, Gilead Abbvie Gilead Sciences, Sciences, Incyte, Pharmacyclics, Incyte, Seattle Genetics Pharmacyclics, Seattle Genetics

Leslie Celltrion Popplewell Hematologic Malignancies-Plasma Cell Dyscrasia Suzanne Caelum Biosciences Bristol-Myers Squibb, Caelum Sanofi Janssen Sorrento Lentzsch Biosciences, Janssen, Novartis Brea Lipe Celgene Celgene (Inst), Cellectar (Inst), Janssen (Inst), Karyopharm Therapeutics (Inst) Philip L. Bristol-Myers Bristol-Myers Squibb, Celgene, Celgene (Inst) McCarthy Squibb, Celgene, Janssen, Karyopharm Janssen, Therapeutics, Magenta, Sanofi, Karyopharm The Binding Site Therapeutics, Sanofi, The Binding Site Noopur S. Raje Amgen, Bristol-Myers Squibb, AstraZeneca (Inst) Celgene, Janssen Oncology, Merck, Novartis, Takeda Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Leah M. Department of ACGME, National Patient-Centered Backhus Veteran Affairs, Lung Cancer Outcomes Stanford Roundtable, Research University Patient-Centered Institute (PCORI) Outcomes Research Institute (PCORI) Robert B. Aduro Biotech, Patents pending Cameron Volition RX for chest tube insertion system and pleurovac electronic bubble detector; all assigned to the University of California

Jamie E. Chaft AstraZeneca/MedImmune, Bristol- AstraZeneca/MedImmune (Inst), Bristol-Myers Squibb (Inst), Myers Squibb, Genentech/Roche, Genentech/Roche (Inst) Merck Alexander Chi Maximilian CiberMed Roche Varian Medical Systems Patent filings on Roche, Varian Medical Diehn ctDNA detection Systems assigned to Stanford University (Inst), Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)

Anna F. Farago Clinical Care Abbvie, Abbvie/Stemcentrx, Abbvie (Inst), Amgen (Inst), AstraZeneca (Inst), Bayer (Inst), Bristol- Abbvie, Options, AstraZeneca, Bayer, Myers Squibb (Inst), Genentech/Roche (Inst), Ignyta (Inst), Loxo Abbvie/Stemcentrx, DAVAOncology, Genentech/Roche, Loxo, (Inst), Merck (Inst), Novartis (Inst), PharmaMar (Inst) AstraZeneca, Bayer, Foundation PharmaMar, Takeda DAVAOncology, Medicine, Medical Genentech/Roche, Loxo, Learning Institute PharmaMar

Jay M. Lee Genentech/Roche Genentech/Roche, Merck Genentech/Roche Jared Weiss Nektar Pfizer AstraZeneca, BioMarck Astellas Pharma (Inst), AstraZeneca/MedImmune (Inst), Celgene Pharmaceuticals, Celgene, EMD (Inst), Merck (Inst), Novartis (Inst), Pfizer (Inst) Serono, G1 Therapeutics, Genentech, Inivata Lung Cancer - Non-small Cell Metastatic Scott J. Antonia Cellular Biomedicine AstraZeneca, AstraZeneca, Boehringer AstraZeneca, Boehringer Group Boehringer Ingelheim, Bristol-Myers Squibb, Ingelheim, Bristol-Myers Ingelheim, Bristol- FLX Bio, Memgen, Merck, Novartis Squibb, FLX Bio, Merck, Myers Squibb, Novartis CBMG, Memgen, Merck, Novartis Hossein Axiom Abbvie, AstraZeneca, BioNTech Bristol-Myers Squibb (Inst), Celgene (Inst), Lilly (Inst), Merck (Inst), Bristol-Myers Squibb, Takeda, Borghaei Biotechnologies, AG, Boehringer Ingelheim, Bristol- Millennium (Inst) Celgene, Clovis University of Bristol-Myers Myers Squibb, Cantargia AB, Oncology, Genentech, Pennsylvania Squibb, Celgene Celgene, EMD Serono, Genentech, Lilly, Merck, Novartis Genmab, Lilly, Merck, Novartis, Pfizer, Regeneron, Trovagene

Robert C. Rain Therapeutics AstraZeneca, Bayer, GreenPeptide, Ignyta (Inst) Licensing Fees Ignyta, Rain Doebele Ignyta, OncoMed, Rain from Abbott Therapeutics, Therapeutics, Roche/Genentech, Molecular for Roche/Genentech Takeda Patent PCT/US2013/0574 95, Licensing fees from Ignyta for biologic materials (Inst), Licensing fees for biologic materials from Genentech (Inst), Licensing fees for patent from Rain Therapeutics

Marina C. AstraZeneca, Boehringer AstraZeneca, Takeda AstraZeneca (Inst), AstraZeneca/MedImmune (Inst), Bristol-Myers Lilly, MSD Oncology, Roche/ Garassino Ingelheim, Bristol-Myers Squibb, Squibb (Inst), MSD (Inst), Roche/Genentech (Inst) Pfizer Genentech Lilly, MSD, Novartis, Roche Christine L. Abbvie, Ascentage Pharma, Bristol- Abbvie (Inst), Bristol-Myers Squibb (Inst), GlaxoSmithKline (Inst), Hann Myers Squibb, Genentech/Roche Merrimack (Inst) Benjamin P. AstraZeneca, Celgene, Levy Genentech/Roche, Lilly, Merck, Pfizer, Takeda Christine M. ARIAD, Cepheid, ARIAD, AstraZeneca, Cepheid, Novartis, Xcovery ARIAD, Cepheid, Lovly Foundation Foundation Medicine, Novartis, Foundation Medicine, Medicine, Novartis, Pfizer, Takeda Novartis, Pfizer, Takeda Pfizer, Takeda

Gregory J. Riely ARIAD (Inst), GlaxoSmithKline (Inst), Infinity Pharmaceuticals (Inst), Patent application Merck Sharp & Dohme Merck (Inst), Millennium (Inst), Mirati Therapeutics (Inst), Novartis submitted covering (Inst), Pfizer (Inst), Roche/Genentech (Inst) pulsatile use of erlotinib to treat or prevent brain metastases (Inst)

Melanoma/Skin Cancers Douglas B. Array Biopharma, Bristol-Myers Bristol-Myers Squibb, Incyte Intellectual Genentech Johnson Squibb, Incyte, Merck, Novartis property and patents pending surrounding use of MHC-II and response to immune therapy

Jason J. Luke Actym Therapeutics 7 Hills Pharma, Actym Abbvie (Inst), Array BioPharma, Boston Biomedical (Inst), Bristol- Serial #15/612,657 Amgen, Array Therapeutics, Aduro Biotech, Myers Squibb (Inst), Celldex (Inst), Checkmate Pharmaceuticals, (Cancer BioPharma, Alphamab Oncology, Amgen, Array Compugen (Inst), Corvus Pharmaceuticals (Inst), Delcath Systems Immunotherapy), AstraZeneca/MedImmun BioPharma, (Inst), Evelo Therapeutics, Five Prime Therapeutics (Inst), FLX Bio, Serial e, Benevir, Bristol-Myers AstraZeneca/MedImmune, Benevir, Genentech/Roche (Inst), Immunocore (Inst), Incyte (Inst), #PCT/US18/36052 Squibb, Castle Bristol-Myers Squibb, Castle Macrogenics (Inst), MedImmune (Inst), Merck (Inst), Novartis (Inst), (Microbiome Biosciences, Checkmate Biosciences, Checkmate Palleon Pharmaceuticals, Pharmacyclics (Inst), Tesaro (Inst), Xencor Biomarkers for Anti- Pharmaceuticals, EMD Pharmaceuticals, Compugen, EMD (Inst) PD-1/PD-L1 Serono, Gilead Sciences, Serono, Gilead Sciences, IDEAYA Responsiveness: IDEAYA Biosciences, Biosciences, Janssen, Jounce Diagnostic, Janssen, Jounce Therapeutics, Mavu Prognostic and Therapeutics, Merck, Pharmaceutical, Merck, Newlink Therapeutic Uses Novartis, Reflexion Genetics, Novartis, Reflexion Thereof) Medical Medical, Spring Bank, Syndax, Tempest Therapeutics, TTC Oncology, Vividion, WntRx

Joshua M. Mammen Janice M. EMD Serono, Amgen, Array BioPharma, Amgen (Inst), AstraZeneca (Inst), Immunocore (Inst), Incyte (Inst), EMD Serono, Merck Amgen, Array Mehnert Pfizer/EMD Serono Boehringer Ingelheim Macrogenics (Inst), Merck (Inst), Novartis (Inst), Polynoma (Inst), Sharp & Dohme BioPharma, Sanofi (Inst) Boehringer Ingelheim, EMD Serono, Merck

Pediatric Oncology Scott C. Bayer Health Borinstein Jacqueline N. Casillas Steven G. Loxo Loxo Curis (Inst), Lilly (Inst), Loxo (Inst), Merck (Inst), Millennium (Inst), Loxo, Roche/Genentech DuBois Novartis (Inst), Roche/Genentech (Inst) Emily K. Slotkin Sarcoma Thierry Alcindor Amgen, Astellas Pharma, Eisai, CytRx Corporation (Inst), Eisai (Inst), EMD Serono (Inst), Epizyme Immune Design, Lilly, Novartis (Inst), Lilly (Inst) Canada Pharmaceuticals, Shire, Taiho Pharmaceutical Rashmi Chugh Portola EMD Serono, Epizyme, Immune AADi (Inst), Advenchen Laboratories (Inst), Epizyme (Inst), MabVax Pharmaceuticals Design, Janssen (Inst), Morphotek (Inst), Novartis (Inst), Pfizer (Inst), Plexxikon

Juneko E. Grilley- Genentech (Inst), MedImmune (Inst), NanoCarrier (Inst), Novartis Olson (Inst), Pfizer (Inst), Seattle Genetics (Inst) Sam S. Yoon Symptoms and Survivorship Michelle C. Janelsins Christine Miaskowski Shoshana M. Cantel Medical, Rosenberg Edwards Lifesciences

Cardinale B. Teva Teva Smith Piyush MartinSrivastava R. Amgen (Inst), Astellas Pharma (Inst), AstraZeneca (Inst), Bayer (Inst), Medivation/Pfizer Stockler Bionomics (Inst), Bristol-Myers Squibb (Inst), Celgene (Inst), Medivation (Inst), Merck Sharp & Dohme (Inst), Pfizer (Inst), Roche (Inst), Sanofi (Inst), Tilray (Inst) Sunil Verma Oncology Amgen, Amgen, AstraZeneca, Daiichi Education AstraZeneca, Sankyo, Lilly, Macrogenics, Boehringer Novartis, Pfizer, Roche/Genentech, Ingelheim, Lilly, Seattle Genetics, Spectrum Merck, Novartis, Pharmaceuticals Pfizer, Roche/ Genentech